000 01478nam a2200421 i 4500
001 ocn963852181
003 BD
005 20170119094943.0
008 161121s2016 dcu l f000 0 eng c
040 _aPUCPR
_beng
_erda
_cGPO
042 _apcc
043 _an-us---
049 _aBDCG
050 _aKF 50
_b.U56
074 _a0575
086 0 _aAE 2.110:114-229
088 _aPublic Law 114-229
099 _aAE 2.110:114-229
110 1 _aUnited States,
_eenacting jurisdiction.
240 1 0 _aAdvancing Hope Act of 2016
245 1 3 _aAn Act to Extend the Pediatric Priority Review Voucher Program.
264 1 _a[Washington, D.C.] :
_b[U.S. Government Publishing Office],
_c[2016]
300 _a[4] pages ;
_c24 cm.
336 _atext
_btxt
_2rdacontent
337 _aunmediated
_bn
_2rdamedia
338 _avolume
_bnc
_2rdacarrier
500 _aShipping list no.: 2017-0061-P.
500 _a"Sept. 29, 2016 (S. 1878)."
500 _a"130 Stat. 943."
500 _a"Public Law 114-229."
500 _aCRDP Project record.
650 0 _aPediatric pharmacology
_xGovernment policy
_zUnited States.
650 0 _aDrugs
_xTesting
_xLaw and legislation
_zUnited States.
650 0 _aDrug development
_xGovernment policy
_zUnited States.
655 7 _aStatutes and codes.
_2lcgft
776 0 8 _iOnline version:
_aUnited States.
_sAdvancing Hope Act of 2016.
_tAct to Extend the Pediatric Priority Review Voucher Program
_w(OCoLC)962731777
942 _2lcc
_c15
999 _c256335
_d256335